Results 91 to 100 of about 27,170 (181)

Protective Action of Antioxidants on Hepatic Damage Induced by Griseofulvin

The Scientific World Journal, 2014
Erythropoietic protoporphyria (EPP) is a disease associated with ferrochelatase deficiency and characterized by the accumulation of protoporphyrin IX (PROTO IX) in erythrocytes, liver, and skin.
M. del C. Martinez, S. G. Afonso, A. M. Buzaleh, A. Batlle   +3 more
doaj   +1 more source

Narrowband UVB phototherapy in erythropoietic protoporphyria:case series

, 2013
Erythropoietic protoporphyria (EPP) is an inherited disorder of the haem metabolic pathway. It causes disabling cutaneous photosensitivity and, sometimes liver disease due to the accumulation of protoporphyrin in blood, liver and other tissues.(1) Holme ...
Sivaramakrishnan, M., Woods, J., Dawe, R.   +2 more
core   +1 more source

Feasibility of cellular bioenergetics as a biomarker in porphyria patients

Molecular Genetics and Metabolism Reports, 2019
Porphyria is a group of metabolic disorders due to altered enzyme activities within the heme biosynthetic pathway. It is a systemic disease with multiple potential contributions to mitochondrial dysfunction and oxidative stress.
Balu Chacko, Matilda Lillian Culp, Joseph Bloomer, John Phillips, Yong-Fang Kuo, Victor Darley-Usmar, Ashwani K. Singal   +6 more
doaj   +1 more source

UK experience of liver transplantation for erythropoietic protoporphyria [PDF]

, 2011
Erythropoietic protoporphyria (EPP) is characterised by excess production of free protoporphyrin from the bone marrow, most commonly due to deficiency of the enzyme ferrochelatase.
Darius F. Mirza, Mirza, DF, Dowman, Joanna K., Joanna K. Dowman, Gunson, Bridget, Newsome, Philip; id_orcid, Gunson, Briget K., Mirza, Darius F., Dowman, Joanna, null null, Badminton, Michael Norman, Philip N. Newsome, UK Liver Selection and Allocation Working Party, Briget K. Gunson, Newsome, Philip N., Mike N. Badminton, Badminton, MN   +16 more
core   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Case report: Xeroderma pigmentosum Group A with erythropoietic protoporphyria in a young Chinese patient [PDF]

Xeroderma pigmentosum is a rare autosomal recessive genodermatoses characterized by a deficiency in nucleotide excision repair. Erythropoietic protoporphyria is a rare inherited metabolic disease caused by the perturbation of heme.
Ming-fang Zhu, Dan Zhao, Shu-hui Wu, Ying-hong Zeng, Ting Xiao   +4 more
core   +1 more source

A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria

, 2009
Background: Erythropoietic protoporphyria (EPP) is known to be inherited in both autosomal dominant and recessive manners. A deleterious mutation in conjunction with a polymorphic wild type allele underlies the molecular basis of the dominant type ...
E. Di Pierro, D. P. Steensma, V. Brancaleoni, C. Li, M.D. Cappellini   +4 more
core   +1 more source

Cimetidine (H2 histamine antagonist), Fexofenadine (H1 histamine antagonist), and Zinc sulphate in the treatment of erythropoietic protoporphyria

Photodiagnosis and Photodynamic Therapy
Background: Erythropoietic protoporphyria (EPP) patients are deficient in the ferrochelatase enzyme which converts protoporphyrin IX (PpIX) into heme, causing PpIX to accumulate in mature erythrocytes and skin.
Hans Christian Wulf, Peter A. Philipsen, Catharina M. Lerche   +2 more
doaj   +1 more source

The Histamine Pathway is a Target to Treat Hepatic Experimental Erythropoietic ProtoporphyriaSummary

Cellular and Molecular Gastroenterology and Hepatology
Background & Aims: Erythropoietic protoporphyria (EPP) is caused by mutations in ferrochelatase, which inserts iron into protoporphyrin-IX (PP-IX) to generate heme.
Ning Kuo, Pei Li, Juliana Bragazzi Cunha, Lu Chen, Jordan A. Shavit, M. Bishr Omary   +5 more
doaj   +1 more source

Molecular characterisation of erythropoietic protoporphyria in South Africa [PDF]

, 2006
Includes bibliographical ...
Parker, Michelle
core